NextPharma Tech Stack

European CDMO specializing in pharma manufacturing across solid, liquid, and sterile dosage forms

Pharmaceutical Manufacturing London, England 1,001–5,000 employees Founded 1946 Public Company

NextPharma is a UK-listed CDMO with 2,400 employees across eight manufacturing centers in Germany, France, Finland, Norway, and the UK. The hiring and project focus reveals a manufacturing-heavy operation scaling process validation, plant optimization, and GMP compliance infrastructure—consistent with a mid-sized contract manufacturer modernizing quality and regulatory systems. Tech stack (SAP, HPLC, SQL, GCP, AutoCAD) reflects traditional pharma manufacturing operations with emerging data collection and automation initiatives.

Tech Stack 12 technologies

Core StackSAP Active Directory AutoCAD Microsoft Office HPLC GCP Visual Basic SQL Excel Windows EcoVadis Microsoft Project

What NextPharma Is Building

◆Challenges

Optimizing manufacturing and packaging plants
Ensuring gmp compliance
Improving safety compliance
Improving asset reliability
Improving site profitability
Budget constraints
Optimizing internal accounts receivable processes
Implementing structured compliance program
Managing whistleblowing system
Compliance reporting

▲Active Projects

Process validation
Plant optimization projects
Data collection for analytical and formulation development
Change control
Automated evaluation and reporting development
Structured compliance program implementation
Whistleblowing system management
Compliance reporting
Document management for analytics
Change request management

Hiring Activity

Steady65 roles · 25 in 30d

Department

Manufacturing

Engineering

Ops

Finance

Research

Quality

Healthcare

Seniority

Mid

Intern

Junior

Senior

Manager

Lead

Company intelligence

Find more companies like NextPharma by tech stack, pain points and active projects

Get started free

About NextPharma

NextPharma manufactures pharmaceutical dosage forms—solids (tablets, capsules), non-sterile liquids (emulsions, syrups), sterile liquids (ophthalmic solutions), and semi-solids (creams, gels)—for pharmaceutical, biotech, nutraceutical, and healthcare clients. The company operates specialized containment areas for hormones, narcotics, penicillin/cephalosporin antibiotics, and highly-potent compounds, plus clinical trial manufacturing services. Founded in 1946 and publicly listed, NextPharma maintains manufacturing hubs in Berlin, Bielefeld, Göttingen, Waltrop, Limay, Ploermel, Tampere, Edinburgh, and Asker. Current organizational priorities center on plant optimization, process validation, compliance infrastructure (GMP, whistleblowing systems, structured compliance programs), and profitability improvements.

HeadquartersLondon, England

Company Size1,001–5,000 employees

Founded1946

Hiring MarketsGermany, France, Finland, Norway

Frequently Asked Questions

What manufacturing capabilities does NextPharma offer?

NextPharma manufactures solids (tablets, hard/soft capsules, powders, controlled-release pellets), non-sterile liquids (emulsions, suspensions, syrups), sterile liquids (ophthalmic/otic solutions), and semi-solids (creams, gels, ointments, suppositories). Specialized containment available for hormones, narcotics, penicillin/cephalosporin antibiotics, and highly-potent compounds.

Where is NextPharma headquartered and how many employees does it have?

NextPharma is headquartered in London, England, and employs 2,400 people across eight manufacturing centers: Berlin, Bielefeld, Göttingen, Waltrop (Germany), Limay, Ploermel (France), Tampere (Finland), Edinburgh (UK), and Asker (Norway).